
SBCVC
Description
SBCVC, formerly known as SoftBank China Venture Capital, is a prominent venture capital and private equity firm with a deep-rooted history in the Chinese investment landscape. Initially established as the China arm of SoftBank, the firm successfully spun out in 2016 to become an independent entity, retaining its strong market presence and investment expertise. Headquartered in Shanghai, SBCVC manages both USD and RMB-denominated funds, enabling it to cater to a diverse range of investment opportunities and investor preferences within China and globally. This strategic independence has allowed SBCVC to further solidify its position as a key player in the region's innovation ecosystem.
The firm primarily focuses on early to growth-stage investments across several high-growth sectors critical to China's economic development. Its core investment areas include Technology, Media, and Telecommunications (TMT), healthcare, clean energy, and consumer goods. SBCVC's investment philosophy emphasizes long-term value creation, partnering with ambitious entrepreneurs to scale their businesses and achieve market leadership. Their extensive experience and local insights provide portfolio companies with valuable strategic guidance and operational support, fostering sustainable growth.
SBCVC has built an impressive portfolio over its operational history, contributing significantly to the success of numerous industry leaders. The firm reportedly manages over $3 billion in assets across various funds, demonstrating its substantial financial capacity and influence. Typical first check sizes for SBCVC generally range from $5 million to $50 million, reflecting its flexibility to invest across different stages from Series A to later growth rounds. This broad range allows them to support promising startups from their initial commercialization phases through to significant market expansion, cementing their reputation as a versatile and impactful investor in the dynamic Chinese market.
Investor Profile
SBCVC has backed more than 29 startups, with 1 new investments in the last 12 months alone. The firm has led 6 rounds, about 21% of its total and boasts 17 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series A rounds (top funding stages).
- Majority of deals are located in China, United States, Australia.
- Strong thematic focus on Software, Health Care, Information Technology.
- Typical check size: $5M – $50M.
Stage Focus
- Series C (21%)
- Series B (21%)
- Series A (17%)
- Series Unknown (17%)
- Seed (10%)
- Series E (7%)
- Private Equity (3%)
- Angel (3%)
Country Focus
- China (72%)
- United States (17%)
- Australia (7%)
- Hong Kong (3%)
Industry Focus
- Software
- Health Care
- Information Technology
- Biotechnology
- Cloud Computing
- Medical
- Semiconductor
- E-commerce
- Marketing
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.